Search by tag «Medicine» 44 results
Gary Hix is a professor of the University of Wolverhampton (the UK) and the head of Wolverhampton School of Sciences. Together with his research team, Prof. Hix designs anti-bacterial medical materials. In an open lecture at ITMO University, he spoke about organic-inorganic hybrid materials, metal phosphonates and oxides, and how these substances are produced. Speaking about anti-bacterial materials, Prof. Hix explained the effect of their structure on the discharge of active substances and how these materials are made to possess therapeutic qualities.
Roman Ivanov, the Vice President of BIOCAD, had once returned to Russia from the Netherlands and has spent ten years in charge of R&D and international relations for the top company on the Russian biotechnology market. During an open lecture at ITMO University’s Biochemistry Cluster, he discussed Russian science, prospects of world-class R&D at the nation’s companies and what students need to know about starting a career in hi-tech. Below are excerpts from his lecture:
Nowadays, a person is considered long-living after they reach 90. In Russia, there are more than seven thousand people like that. Most of them live in Siberia, Caucasus and the Asian part of the country. According to statistics, there has only been 16 people documented to having lived for over 116 years. Longevity became the topic of the recent Break Down to Atoms talk show that was conducted by the Information Centre for Nuclear Energy in St. Petersburg for the 19th time. Among the event’s speakers was professor Vladimir Khavinson, Director of the St. Petersburg Institute of Bioregulation and Gerontology who’s been focusing on the issues of longevity for the past 35 years. The expert spoke about a recent research where scientists proved that prolonging one’s life by 40% is possible, discussed the role of signal peptides in human longevity, and explained why epithalamin is the best drug on Earth.
Cancer is one of the most common diseases of our time, and trailblazing bioinformatics research is looking for answers. This rapidly developing scientific field has already come up with effective methods that not only allow to quickly track down genome changes conducive to cancer development, but also pinpoint the factors that catalyze or inhibit this process. These questions were at the center of this year’s Bioinformatics summer school held at the end of July in the green purlieus of St. Petersburg. Participants of this largest national Bioinformatics event conducted high-profile research breaking down medical data of breast cancer patients, analyzing the differential expression of long non-coding RNA in kidney renal cell carcinoma, and building phylogenetic trees that contribute to better understanding of the disease. ITMO.NEWS met the young scientists to talk about their summer school projects and the latest of cancer-focused bioinformatics research.
At the beginning of this year, Master’s students and graduates of ITMO’s Science Communication program launched Profilaktika.Media, an educational media project from the Cancer Prevention Foundation. Before the year ends, they plan to launch a column “A guide to cancer types”, as well as publish instructions for oncology patients facing complex situations. In an interview for ITMO.NEWS, the project’s editor Polina Poleschuk and author Lizaveta Babitskaya talked about writing about oncology for a wider audience, trust issues in medicine, and why one shouldn’t believe everything they find on such resources as PubMed.
Musculoskeletal system diseases do not only worsen the quality of life but they can also lead to other diseases, including cardiovascular ones. Scoliosis is one of the most common musculoskeletal system diseases. Researchers from ITMO’s Department of Nano-Photonics and Metamaterials and Department of Advanced Mathematics together with the Ogonek Pediatric Orthopedics and Traumatology Center (Strelna), headed by Mikhail Dudin, are working on a physical and mathematical model of scoliosis that will help doctors more accurately diagnose the disease.
Every year more and more devices emerge that help us monitor our health. Many people, and especially the younger generations, enjoy using various gadgets to track the amount of exercise they do, their diet and daily routine. These devices can help us move forward from reactive healthcare to preventative healthcare. Dr. Anthony Faiola, is Professor and Head of the Biomedical and Health Information Sciences Department at the University of Illinois at Chicago, gave a keynote at the conference “Digital Transformation & Global Society” (DTGS) at ITMO University. He spoke about recent developments regarding mobile health information technology, and how his team uses them. Here are the highlights of his report.
From June 4-8, St. Petersburg hosted the second international Lasers&Photonics congress, which brought together 1,500 scientists, researchers and members of the industry in the fields of photonics, laser physics and quantum communications. One of the main events at the congress was an exhibition where companies from Russia, Belarus, Lithuania and Japan presented their products; ITMO University, too, showcased devices developed in cooperation with industrial partners. Holographic nanocomposite materials, Li-Fi devices, infrared sensors for high-speed fiber optic communications – these and other inventions are market-ready.
An international research team has studied a new cell visualisation and drug delivery system based on nanoparticles coated with luminescent dye molecules. Scientists have found out that the particle material and the distance between the dye and the particle’s surface affect the intensity of the luminescent signal. It turned out that silicon nanoparticles coated with dye molecules are more efficient than similar particles made of gold. Thanks to their biocompatibility, silicon particles can be used for cell visualisation and drug delivery. The research was published in Scientific Reports.
Scientists from ITMO University’s international research laboratory SCAMT, together with developers from Aira and information security experts, are developing a system for end-to-end monitoring of the manufacturing of medical and chemical products. The system is based on the lab’s “Nanodoctor” – a chlorine dioxide-based drug capable of neutralizing nearly all viruses and bacteria. Among its advantages are an improved structure that prevents the accumulation of harmful substances during manufacturing, and a new quality control system based on blockchain technology. The project’s concept allows end customers to learn about each of the production stages using a QR code printed on the packaging and make sure that the process occurred without any infractions and the active ingredient content is within the stated amount.